Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
| Actual shortage: | 243 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2023-07-07 | 2023-09-01 | 197872 |
| APO-VALSARTAN | 80MG | TABLET | Resolved | 2017-03-10 | 2019-03-08 | 272 |
| APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2017-03-10 | 2017-06-05 | 327 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 712 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-04-07 | 2017-06-27 | 5891 |
| APO-TELMISARTAN | 80MG | TABLET | Resolved | 2017-05-24 | 2017-10-03 | 11047 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2017-06-27 | 2017-10-27 | 14065 |
| APO-PROPRANOLOL | 80MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18910 |
| APO-SOTALOL | 80MG | TABLET | Resolved | 2017-09-04 | 2018-01-19 | 20906 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2017-10-17 | 2018-05-22 | 26159 |
| APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2018-02-13 | 2018-05-01 | 39641 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-02-13 | 2018-03-20 | 39673 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2018-05-01 | 2018-09-11 | 47680 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2018-05-02 | 2018-07-12 | 47972 |
| APO-SOTALOL | 80MG | TABLET | Resolved | 2018-07-04 | 2018-07-13 | 54187 |
| APO-TELMISARTAN | 80MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55798 |
| APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2018-08-09 | 2018-11-03 | 57789 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2019-03-13 | 2019-04-05 | 78555 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-05-15 | 2019-05-18 | 84115 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-11-27 | 2020-04-06 | 99795 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |